[go: up one dir, main page]

GB0329693D0 - Compounds useful in therapy - Google Patents

Compounds useful in therapy

Info

Publication number
GB0329693D0
GB0329693D0 GB0329693A GB0329693A GB0329693D0 GB 0329693 D0 GB0329693 D0 GB 0329693D0 GB 0329693 A GB0329693 A GB 0329693A GB 0329693 A GB0329693 A GB 0329693A GB 0329693 D0 GB0329693 D0 GB 0329693D0
Authority
GB
United Kingdom
Prior art keywords
therapy
compounds useful
compounds
useful
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0329693A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PFIZER Ltd
Pfizer Ltd Great Britain
Original Assignee
PFIZER Ltd
Pfizer Ltd Great Britain
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to GB0329693A priority Critical patent/GB0329693D0/en
Application filed by PFIZER Ltd, Pfizer Ltd Great Britain filed Critical PFIZER Ltd
Publication of GB0329693D0 publication Critical patent/GB0329693D0/en
Priority to EA200600925A priority patent/EA010132B1/en
Priority to AU2004309164A priority patent/AU2004309164B2/en
Priority to CA2551038A priority patent/CA2551038C/en
Priority to CN2004800384928A priority patent/CN1898244B/en
Priority to OA1200600206A priority patent/OA13347A/en
Priority to EP04801354A priority patent/EP1701959A1/en
Priority to HK07102965.0A priority patent/HK1095822B/en
Priority to KR1020067012328A priority patent/KR100854872B1/en
Priority to UAA200606951A priority patent/UA85692C2/en
Priority to PCT/IB2004/004059 priority patent/WO2005063754A1/en
Priority to BRPI0417267-1A priority patent/BRPI0417267A/en
Priority to GEAP20049469A priority patent/GEP20084571B/en
Priority to AP2006003631A priority patent/AP2331A/en
Priority to JP2006546356A priority patent/JP4698604B2/en
Priority to US11/009,768 priority patent/US7745630B2/en
Priority to TW093139507A priority patent/TWI287541B/en
Priority to UY28693A priority patent/UY28693A1/en
Priority to ARP040104826A priority patent/AR047340A1/en
Priority to NL1027833A priority patent/NL1027833C2/en
Priority to DO2004001062A priority patent/DOP2004001062A/en
Priority to GT200400275A priority patent/GT200400275A/en
Priority to PA20048620501A priority patent/PA8620501A1/en
Priority to PE2005000032A priority patent/PE20051051A1/en
Priority to IS8472A priority patent/IS8472A/en
Priority to ZA200604096A priority patent/ZA200604096B/en
Priority to IL176349A priority patent/IL176349A/en
Priority to EC2006006647A priority patent/ECSP066647A/en
Priority to TNP2006000196A priority patent/TNSN06196A1/en
Priority to CR8481A priority patent/CR8481A/en
Priority to MA29125A priority patent/MA28393B1/en
Priority to NO20063380A priority patent/NO20063380L/en
Priority to US12/777,522 priority patent/US8093400B2/en
Ceased legal-status Critical Current

Links

GB0329693A 2003-12-22 2003-12-22 Compounds useful in therapy Ceased GB0329693D0 (en)

Priority Applications (33)

Application Number Priority Date Filing Date Title
GB0329693A GB0329693D0 (en) 2003-12-22 2003-12-22 Compounds useful in therapy
JP2006546356A JP4698604B2 (en) 2003-12-22 2004-12-09 Triazole derivatives as vasopressin antagonists
EP04801354A EP1701959A1 (en) 2003-12-22 2004-12-09 Triazole derivatives as vasopressin antagonists
KR1020067012328A KR100854872B1 (en) 2003-12-22 2004-12-09 Triazole Derivatives as Vasopressin Antagonists
CA2551038A CA2551038C (en) 2003-12-22 2004-12-09 Triazole derivatives as vasopressin antagonists
CN2004800384928A CN1898244B (en) 2003-12-22 2004-12-09 Triazole derivatives as vasopressin antagonists
OA1200600206A OA13347A (en) 2003-12-22 2004-12-09 Triazole derivatives as vasopressin antagonists.
EA200600925A EA010132B1 (en) 2003-12-22 2004-12-09 Triazole derivatives as vasopressin antagonists
HK07102965.0A HK1095822B (en) 2003-12-22 2004-12-09 Triazole derivatives as vasopressin antagonists
AU2004309164A AU2004309164B2 (en) 2003-12-22 2004-12-09 Triazole derivatives as vasopressin antagonists
UAA200606951A UA85692C2 (en) 2003-12-22 2004-12-09 Triazole derivatives as vasopressin antagonists
PCT/IB2004/004059 WO2005063754A1 (en) 2003-12-22 2004-12-09 Triazole derivatives as vasopressin antagonists
BRPI0417267-1A BRPI0417267A (en) 2003-12-22 2004-12-09 triazole derivatives as vasopressin antagonists
GEAP20049469A GEP20084571B (en) 2003-12-22 2004-12-09 Triazole derivatives as vasopressin antagonists
AP2006003631A AP2331A (en) 2003-12-22 2004-12-09 Triazole derivatives as vasopressin antagonists.
US11/009,768 US7745630B2 (en) 2003-12-22 2004-12-10 Triazolyl piperidine arginine vasopressin receptor modulators
TW093139507A TWI287541B (en) 2003-12-22 2004-12-17 Compounds useful in therapy
UY28693A UY28693A1 (en) 2003-12-22 2004-12-21 USEFUL COMPOUNDS IN THERAPY
NL1027833A NL1027833C2 (en) 2003-12-22 2004-12-21 Compounds useful in therapy.
ARP040104826A AR047340A1 (en) 2003-12-22 2004-12-21 TRIAZOL DERIVATIVES AS RECEIVER ANTAGONISTS VI A
DO2004001062A DOP2004001062A (en) 2003-12-22 2004-12-22 USEFUL COMPOUNDS IN THERAPY
GT200400275A GT200400275A (en) 2003-12-22 2004-12-22 USEFUL COMPOUNDS IN THERAPY
PA20048620501A PA8620501A1 (en) 2003-12-22 2004-12-22 USEFUL COMPOUNDS IN THERAPY
PE2005000032A PE20051051A1 (en) 2003-12-22 2005-01-03 TRIAZOLE COMPOUNDS AS VASOPRESSIN ANTAGONISTS
IS8472A IS8472A (en) 2003-12-22 2006-05-18 Triazole derivatives as a diuretic
ZA200604096A ZA200604096B (en) 2003-12-22 2006-05-22 Triazole derivatives as vasopressin antagonists
EC2006006647A ECSP066647A (en) 2003-12-22 2006-06-15 TRIAZOL DERIVATIVES AS VASOPRESINE ANTAGONISTS
IL176349A IL176349A (en) 2003-12-22 2006-06-15 Piperidinyl triazole derivatives as v1a vasopressin receptor antagonists
TNP2006000196A TNSN06196A1 (en) 2003-12-22 2006-06-21 TRIAZOLE DERIVATIVES AS ANTAGONISTS OF VASOPRESSIN
CR8481A CR8481A (en) 2003-12-22 2006-06-22 TRIAZOL DERIVATIVES AS VASOPRESINE ANTAGONISTS
MA29125A MA28393B1 (en) 2003-12-22 2006-06-22 Triazole derivatives as antagonists of vasopressin
NO20063380A NO20063380L (en) 2003-12-22 2006-07-21 Triazole derivatives as vasopressin antagonists
US12/777,522 US8093400B2 (en) 2003-12-22 2010-05-11 Compounds useful in therapy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0329693A GB0329693D0 (en) 2003-12-22 2003-12-22 Compounds useful in therapy

Publications (1)

Publication Number Publication Date
GB0329693D0 true GB0329693D0 (en) 2004-01-28

Family

ID=30776272

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0329693A Ceased GB0329693D0 (en) 2003-12-22 2003-12-22 Compounds useful in therapy

Country Status (6)

Country Link
CN (1) CN1898244B (en)
GB (1) GB0329693D0 (en)
GT (1) GT200400275A (en)
TN (1) TNSN06196A1 (en)
UA (1) UA85692C2 (en)
ZA (1) ZA200604096B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102010040924A1 (en) * 2010-09-16 2012-03-22 Bayer Schering Pharma Aktiengesellschaft Substituted phenylacet and phenylpropanamides and their use
JP5787237B2 (en) * 2010-10-01 2015-09-30 大正製薬株式会社 1,2,4-triazolone derivatives
CN104098520B (en) * 2014-07-23 2016-01-20 张远强 Phenyltriazole schiff base compounds, Preparation Method And The Use
KR20170048588A (en) * 2014-09-17 2017-05-08 카리라 파마슈티컬스, 아이앤씨. Bicyclic compounds
CN110108682B (en) * 2019-05-08 2021-09-24 济南大学 Application of Several Atypical Red Light Silicon-Containing Dyes

Also Published As

Publication number Publication date
UA85692C2 (en) 2009-02-25
GT200400275A (en) 2005-08-18
ZA200604096B (en) 2007-11-28
CN1898244B (en) 2011-06-22
TNSN06196A1 (en) 2007-11-15
CN1898244A (en) 2007-01-17

Similar Documents

Publication Publication Date Title
GB0206033D0 (en) Compounds useful in therapy
GB0303852D0 (en) Triazole compounds useful in therapy
GB0307918D0 (en) Therapeutic use
GB0303910D0 (en) Therapeutic agents
GB0324761D0 (en) Use of compounds in therapy
GB0313250D0 (en) Therapeutic agents
GB0400700D0 (en) Compounds useful in therapy
GB0323258D0 (en) Therapeutic compounds
GB0311859D0 (en) Therapeutic agents
GB0311201D0 (en) Therapeutic agents
GB0301350D0 (en) Therapeutic agents
SI1597260T1 (en) Triazole compounds useful in therapy
GB0329693D0 (en) Compounds useful in therapy
GB0304524D0 (en) Therapeutic agents
GB0303289D0 (en) Combination therapy
GB0325021D0 (en) Therapeutic combinations
GB0401384D0 (en) Compounds useful in therapy
GB0318311D0 (en) Combination therapy
GB0329512D0 (en) Combination therapy
GB0316184D0 (en) Combination therapy
GB0316181D0 (en) Combination therapy
GB0316176D0 (en) Combination therapy
GB0314100D0 (en) Combination therapy
GB0314097D0 (en) Combination therapy
GB0307560D0 (en) Combination therapy

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)